Hasil Pencarian - Ari Vanderwalde
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 10 hasil dari 10
-
1
-
2
180 Evaluation of association of mutation in ARID family of genes with outcomes in cutaneous melanoma oleh Ari VanderWalde, Andrew Elliott, George Ansstas, Soo Park, Kevin Kim, George P Souroullas, Tolulope Adeyelu
Diterbitkan 2023-11-01Artikel -
3
-
4
-
5
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma oleh Jordan Phillipps, George Nassief, Renee Morecroft, Tolulope Adeyelu, Andrew Elliott, Farah Abdulla, Ari Vanderwalde, Soo Park, Omar Butt, Alice Zhou, George Ansstas
Diterbitkan 2024-09-01Dapatkan teks lengkap
Artikel -
6
1508 Analyzing the genomic, transcriptomic and immune landscapes associated with surface somatostatin receptor 2 (SSTR2) gene expression in nasopharyngeal carcinoma (NPC) oleh James L Gulley, Ari VanderWalde, Emil Lou, Nishant Gandhi, Heloisa Soares, Charalampos S Floudas, Dara Bracken-Clarke, Harris Krause, Minh Phan, Rusha Patel, Phillip Walker
Diterbitkan 2023-11-01Artikel -
7
1509 Characterizing somatostatin receptor 2 (SSTR2) expression and the immune landscape of olfactory neuroblastoma (ONB), sinonasal neuroendocrine carcinoma (SNEC), and sinonasal u... oleh James L Gulley, Ari VanderWalde, Emil Lou, Nishant Gandhi, Heloisa Soares, Charalampos S Floudas, Dara Bracken-Clarke, Harris Krause, Alex Farrell, Minh Phan, Rusha Patel, Nyall London
Diterbitkan 2023-11-01Artikel -
8
ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes oleh Favour A. Akinjiyan, George Nassief, Jordan Phillipps, Tolulope Adeyelu, Andrew Elliott, Farah Abdulla, Alice Y. Zhou, George Souroullas, Kevin B. Kim, Ari Vanderwalde, Soo J. Park, George Ansstas
Diterbitkan 2024-02-01Dapatkan teks lengkap
Artikel -
9
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing oleh Misako Nagasaka, Shannon S. Zhang, Yasmine Baca, Joanne Xiu, Jorge Nieva, Ari Vanderwalde, Jeffrey J. Swensen, David Spetzler, Wolfgang Michael Korn, Luis E. Raez, Stephen V. Liu, Sai-Hong Ignatius Ou
Diterbitkan 2023-10-01Dapatkan teks lengkap
Artikel -
10
506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 ± nivolumab in patients with advanced solid tumors oleh Anna Olsson-Brown, Joseph Sacco, Mark Middleton, Jason Chesney, Mohammed Milhem, Kevin Harrington, Robert Coffin, Katy Tsai, Adel Samson, Bartosz Chmielowski, Ari VanderWalde, Andrea Pirzkall, Jiaxin Niu, Praveen Bommareddy, Georgia Beasley, Gino In, Terence Rhodes, Francesca Aroldi, Lavita Menezes, Tawnya Bowles, Hamid Emamekhoo, Scott Baum, Sophie Dalac-Rat, Katharina Kahler, Eva Muñoz
Diterbitkan 2021-11-01Artikel